shortagewatch

Home / Digestive tract and metabolism / Metformin and Dapagliflozin

ATC A10BD15 · Combinations of Oral Blood Glucose Lowering Drugs

Metformin and Dapagliflozin shortage

As of 2 Nov 2026, Metformin and Dapagliflozin has a reported shortage in 1 of the 16 countries we track (Canada), covering 4 products from 1 company.

Countries1/16
Products4packs or presentations
Companies10 listed
Short since4 May 20266 months ago
Earliest return4 Dec 2026company estimate
Main reasonManufacturing problem
United StatesNo reported shortageCanada4 products shortGermanyNo reported shortageFranceNo reported shortageItalyNo reported shortageSpainNo reported shortageIrelandNo reported shortageAustriaNo reported shortageBelgiumNo reported shortageSwitzerlandNo reported shortageCzechiaNo reported shortageNorwayNo reported shortageSwedenNo reported shortageJapanNo reported shortageNew ZealandNo reported shortageAustraliaNo reported shortage

Timeline

Canada
2027APO-DAPAGLIFLOZIN-METFORMIN (60 BTL)APO-DAPAGLIFLOZIN-METFORMIN (60 BTL)APO-DAPAGLIFLOZIN-METFORMIN (60 BTL)APO-DAPAGLIFLOZIN-METFORMIN (60 BTL)APO-DAPAGLIFLOZIN-METFORMIN (60 BTL)APO-DAPAGLIFLOZIN-METFORMIN (60 BTL)APO-DAPAGLIFLOZIN-METFORMIN (60 BTL)APO-DAPAGLIFLOZIN-METFORMIN (60 BTL)today

Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.

Which companies are short

products short, all countries
Apotex4

Compared with similar medicines

ATC group A10BD · Combinations of Oral Blood Glucose Lowering Drugs
Metformin and Sitagliptin3/16Metformin and Vildagliptin3/16Metformin and Canagliflozin2/16Glimepiride and Pioglitazone1/16Metformin and Dapagliflozin1/16Metformin and Pioglitazone1/16Metformin and Sulfonylureas1/16

Affected products

CountryProductCompanySinceExpected backReason
CAAPO-DAPAGLIFLOZIN-METFORMIN (60 BTL) limitedAPOTEX INC4 May 20264 Dec 2026Manufacturing problem
Disruption of the manufacture of the drug
CAAPO-DAPAGLIFLOZIN-METFORMIN (60 BTL)APOTEX INC4 Sep 2026not givenManufacturing problem
Disruption of the manufacture of the drug
CAAPO-DAPAGLIFLOZIN-METFORMIN (60 BTL)APOTEX INC22 Sep 202618 Dec 2026Manufacturing problem
Disruption of the manufacture of the drug
CAAPO-DAPAGLIFLOZIN-METFORMIN (60 BTL)APOTEX INC25 Sep 2026not givenManufacturing problem
Disruption of the manufacture of the drug

"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.